Corbus Pharmaceuticals Holdings (CRBP) Net Income (QoQ) (2013 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) Net Income (QoQ) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 475.46 Bn | 470.67 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.19 Bn | 115.94 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.44 Bn | 60.69 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.20 Bn | 63.20 Bn | - |
| 8 | Argenx Se | 57.08 Bn | 51.90 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.11 Bn | 38.11 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 115.93 Mn | 88.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1,958.22% |
| Jun 30, 2025 | 196.69% |
| Mar 31, 2025 | -173.38% |
| Dec 31, 2024 | 110.23% |
| Sep 30, 2024 | 21.83% |
| Jun 30, 2024 | -12,353.97% |
| Mar 31, 2024 | 101.76% |
| Dec 31, 2023 | 64.61% |
| Sep 30, 2023 | -4.66% |
| Jun 30, 2023 | -58.82% |
| Mar 31, 2023 | -72.45% |
| Dec 31, 2022 | 44.82% |
| Sep 30, 2022 | 17.27% |
| Jun 30, 2022 | -151.74% |
| Mar 31, 2022 | 11.81% |
| Dec 31, 2021 | 80.19% |
| Sep 30, 2021 | 2.38% |
| Jun 30, 2021 | -4.27% |
| Mar 31, 2021 | -146.67% |
| Dec 31, 2020 | 69.21% |